Mechanistic imbalance of pulmonary vasomotor control in progressive lung injury

被引:17
作者
Fullerton, DA
Hahn, AR
McIntyre, RC
机构
[1] Cardiothoracic Surgery, Colorado Univ. Health Sciences Ctr., Box C-310, Denver, CO 80262
关键词
D O I
10.1016/S0039-6060(96)80220-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Pulmonary hypertension is the major hemodynamic feature of progressive lung injury. We hypothesized that the mechanisms of pulmonary vasorelaxation become progressively impaired in progressive lung injury. The purpose of this study was to examine the following mechanisms of pulmonary vasorelaxation in a rat model of monocrotaline-induced progressive lung injury: endothelial-dependent cyclic guanosine monophosphate-mediated relaxation (response to acetylcholine), endothelial-independent cyclic guanosine monophosphate-mediated relaxation (response to nitroprusside), beta-adrenergic cyclic adenosine monophosphate-mediated relaxation (response to isoproterenol), and hypoxic pulmonary vasoconstriction. Methods. Rats were studied 2, 7, and 14 days after monocrotaline injection (100 mg/kg intraperitoneally). Pulmonary vasomotor control mechanisms were studied in isolated pulmonary artery rings. Controls were studied 14 days after saline injection. Statistical analysis was by ANOVA; p < 0.05 was considered significant. Results. A progressive impairment of pulmonary vasorelaxation was observed. By 14 days after monocrotaline injection acetylcholine produced only 25% +/- 5% relaxation versus 95% +/- 5% in controls (p < 0.05), nitroprusside produced 46% +/- 5% relaxation versus 100% in controls (p < 0.05), and isoproterenol produced only 18% +/- 5% relaxation versus 94% +/- 4% in controls (p < 0.05). At the same time hypoxic pulmonary vasoconstriction became progressively exaggerated. Conclusions. Progressive dysfunction of pulmonary vasomotor control may contribute to the pulmonary hypertension seen in progressive lung injury.
引用
收藏
页码:98 / 103
页数:6
相关论文
共 31 条
[1]  
ALTIERE RJ, 1986, J PHARMACOL EXP THER, V236, P390
[2]  
BACHOFEN M, 1982, CLIN CHEST MED, V3, P35
[3]   LESIONS IN LUNGS + LIVERS OF RATS POISONED WITH PYRROLIZIDINE ALKALOID FULVINE + ITS N-OXIDE [J].
BARNES, JM ;
SCHOENTAL, R ;
MAGEE, PN .
JOURNAL OF PATHOLOGY AND BACTERIOLOGY, 1964, 88 (02) :521-+
[4]   LOW-DOSE PGI2 PREVENTS MONOCROTALINE-INDUCED THROMBOXANE PRODUCTION AND LUNG INJURY [J].
CZER, GT ;
MARSH, J ;
KONOPKA, R ;
MOSER, KM .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 60 (02) :464-471
[5]  
FISHMAN AP, 1985, HDB PHYSL 3, V1, P93
[6]   PULMONARY VASCULAR SMOOTH-MUSCLE RELAXATION BY CGMP-MEDIATED VERSUS CAMP-MEDIATED MECHANISMS [J].
FULLERTON, DA ;
HAHN, AR ;
BANERJEE, A ;
HARKEN, AH .
JOURNAL OF SURGICAL RESEARCH, 1994, 57 (02) :259-263
[7]   DYSFUNCTION OF CGMP-MEDIATED PULMONARY VASORELAXATION IN ENDOTOXIN-INDUCED ACUTE LUNG INJURY [J].
FULLERTON, DA ;
MCINTYRE, RC ;
HAHN, AR ;
AGRAFOJO, J ;
KOIKE, K ;
MENG, XZ ;
BANERJEE, A ;
HARKEN, AH .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (06) :L1029-L1035
[8]   VASCULAR HYPERRESPONSIVENESS IN PERFUSED LUNGS FROM MONOCROTALINE-TREATED RATS [J].
GILLESPIE, MN ;
OLSON, JW ;
REINSEL, CN ;
OCONNOR, WN ;
ALTIERE, RJ .
AMERICAN JOURNAL OF PHYSIOLOGY, 1986, 251 (01) :H109-H114
[9]  
GWITNER GH, 1983, J APPL PHYSIOL, V55, P949
[10]   PNEUMOTOXICITY AND THROMBOCYTOPENIA AFTER SINGLE INJECTION OF MONOCROTALINE [J].
HILLIKER, KS ;
BELL, TG ;
ROTH, RA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (04) :H573-H579